Hepatitis B virus infection in HIV-positive population in Brazil: Results of a survey in the state of Mato Grosso and a comparative analysis with other regions of Brazil

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  de Almeida Pereira, Rui Alberto Roldão ^a   Mussi, Aparecida Duarte Hg ^b   de Azevedo e Silva, Verginía Correa ^b   Souto, Francisco José Dutra ^a,c  

^a UNIVERSITY OF CUIABÁ   (Brazil)

^b Laboratório Central de Mato Grosso   (Brazil)

^c UNIVERSIDADE FEDERAL DE MATO GROSSO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS DELTA ANTIGEN; HEPATITIS B ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD GROUP TYPING; BRAZIL; CONTROLLED STUDY; DELTA AGENT HEPATITIS; DISEASE MARKER; EXPOSURE; FEMALE; FOLLOW UP; GROUPS BY AGE; HEALTH CARE PERSONNEL; HEALTH SURVEY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIVIDUALITY; INFECTION RISK; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT PARTICIPATION; POPULATION RESEARCH; PREVALENCE; PUBLIC HEALTH SERVICE; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; SAMPLE SIZE; SEX DIFFERENCE; SEXUALITY; TATTOOING; VIRUS LOAD; BLOOD; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; HETEROZYGOTE; MIDDLE AGED; RISK FACTOR;

ADOLESCENT; ADULT; AGED; BRAZIL; CARRIER STATE; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 33645471396     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-34     Document Type: Article

References (24)

1. Mahoney FJ: Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev 1999, 12:351-366.
2. Souto FJD: Distribuição da hepatite B no Brasil: atualização do mapa epidemiológico e proposições para seu controle. Gastroenterol Endosc Digest 1999, 18:143-150.
3. Rustgi VK, Hoofnagle JH, Gerin GL, Gelmann EP, Reichert CM, Cooper JN, Macher AM: Hepatitis B infection in the acquired immunodeficiency syndrome. Ann Intern Med 1984, 101:795-797.
4. Thio CL: Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment. Semin Liver Dis 2003, 23:125-36.
5. Thio CL, Seaberg EC, Skolasky RL, Phair J, Visscher B, Munoz A, Thomas DL: HIV-I, hepatitis B virus, and risk of liver-related mortality in the Multicenter AIDS Cohort Study (MACS). Lancet 2002, 360:1921-1926.
6. Lazizi Y, Grangeot-Keros L, Delfraissy JF, Boue F, Dubreuil P, Badur S, Pillot J: Reappearance of hepatitis B virus in immune patients infected with the human immunodeficiency virus type I. J Infect Dis 1988, 158:666-667.
7. Gilson RJC, Hawkins AE, Beecham MR, Ross E, Waite J, Briggs M, McNally T, Kelly GE, Tedder RS, Weller IV: Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS 1997, 11:597-606.
8. Colin JF, Cazals-Hatem D, Loriot MA, Martinot-Peignoux M, Pham BN, Auperin A, Degot C, Benhamou JP, Erlinger S, Valla D, Marcellin P: Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology 1999, 29:1306-1310.
9. Treitinger A, Spada C, Silva EL, Miranda AFB, Oliveira OV, Silveira MVS, Verdi JC, Abdalla DSP: Prevalence of serologic markers of HBV and HCV infection in HIV-I seropositive patients in Florianópolis, Brazil. Braz J Infect Dis 1999, 3:1-5.
10. Souza MG, Passos AD, Machado AA, Figueiredo JF, Esmeraldino LE: HIV and hepatitis B virus co-infection: prevalence and risk factors. Rev Soc Bras Med Trop 2004, 37:391-395.
11. Pavan MH, Aoki FH, Monteiro DT, Goncales NS, Escanhoela CA, Goncales Junior FL: Viral hepatitis In patients infected with human immunodeficiency virus. Braz J Infect Dis 2003, 7:253-261.
12. Correa MCJM, Barone AA, Cavalheiro NP, Tengan FM, Guastini C: Prevalence of hepatitis B in the sera of patients with HIV infection in São Paulo, Brazil. Rev Inst Med Trop S Paulo 2000, 42:81-85.
13. Monteiro MR, do Nascimento, MM, Passos AD, Figueiredo JF: Soroepidemiological survey of hepatitis B virus among HIV/AIDS patients in Belem, Para - Brasil. Rev Soc Bras Med Trop 2004, 37(Suppl 2):27-32.
14. Uneke CJ, Ogbu O, Inyama PU, Anyanwu GI, Njoku MO, Idoko JH: Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria. Mem Inst Oswaldo Cruz 2005, 100:13-16.
15. Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C, Zilmer K, Vella S, Kirk O, Lundgren JD, EuroSIDA Group: Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 2005, 19:593-601.
16. Bensabath G, Hadler S, Scares MC, Fields H, Maynard J: Características serológicas y de la hepatitis vírica aguda en la cuenca amazónica del Brasil. Bol Of Sanit Panam 1987, 103:351-356.
17. Arboleda M, Castilho MC, Fonseca JCF, Albuquerque BC, Sabóia RC, Yoshida CFT: Epidemiological aspects of hepatitis B and D virus infection in the northern region of Amazonas, Brazil. Trans Royal Soc Trap Med Hyg 1995, 89:481-483.
18. Souto FJD, Fontes CJF, Oliveira SS, Yonamine F, dos Santos DRL, Gaspar AMC: Prevalência da hepatite B em área rural de município hiperendêmico na Amazônia mato-grossense: situação epidemiológica. Epidemiol Serv Saude 2004, 13:93-102.
19. Centers for Disease Control and Prevention: 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. MMWR 1999, 48:1-82.
20. Bruguera M, Cremades M, Salinas R, Costa J, Grau M, Sans J: Impaired response to recombinant hepatitis B vaccine in HIV-Infected persons. J Clin Gastroenterol 1992, 14:27-30.
21. Keet IP, van Doornum G, Safary A, Coutinho RA. Insufficient response to hepatitis B vaccination in HIV-positive homosexual men. AIDS 1992, 6:509-510.
22. Fonseca MO, Pang LW, de Paula Cavalheiro N, Barone AA, Heloisa Lopes M: Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose. Vaccine 2005, 23:2902-8.
23. Rey D, Krantz V, Partisani M, Schmitt MP, Meyer P, Libbrecht E, Wendling MJ, Vetter D, Nicolle M, Kempf-Durepaire G, Lang JM: Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-I viral load. Vaccine 2000, 18:1161-1165.
24. Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity. Lancet 2000, 355:561-565.